GB202117642D0 - Methods of cardiomyocyte production - Google Patents
Methods of cardiomyocyte productionInfo
- Publication number
- GB202117642D0 GB202117642D0 GBGB2117642.5A GB202117642A GB202117642D0 GB 202117642 D0 GB202117642 D0 GB 202117642D0 GB 202117642 A GB202117642 A GB 202117642A GB 202117642 D0 GB202117642 D0 GB 202117642D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- methods
- cardiomyocyte production
- cardiomyocyte
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 210000004413 cardiac myocyte Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/99—Serum-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2117642.5A GB202117642D0 (en) | 2021-12-07 | 2021-12-07 | Methods of cardiomyocyte production |
PCT/EP2022/084633 WO2023104813A1 (en) | 2021-12-07 | 2022-12-06 | Methods of cardiomyocyte production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2117642.5A GB202117642D0 (en) | 2021-12-07 | 2021-12-07 | Methods of cardiomyocyte production |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202117642D0 true GB202117642D0 (en) | 2022-01-19 |
Family
ID=80080920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2117642.5A Ceased GB202117642D0 (en) | 2021-12-07 | 2021-12-07 | Methods of cardiomyocyte production |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202117642D0 (en) |
WO (1) | WO2023104813A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9234176B2 (en) * | 2012-11-13 | 2016-01-12 | The Board Of Trustees Of The Leland Stanford Junior University | Chemically defined production of cardiomyocytes from pluripotent stem cells |
EP3765486A4 (en) * | 2018-03-16 | 2022-03-02 | The Board of Trustees of the Leland Stanford Junior University | Reagents and methods with wnt agonists and bioactive lipids for generating and expanding cardiomyocytes |
-
2021
- 2021-12-07 GB GBGB2117642.5A patent/GB202117642D0/en not_active Ceased
-
2022
- 2022-12-06 WO PCT/EP2022/084633 patent/WO2023104813A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2023104813A1 (en) | 2023-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL3942107T3 (en) | Production method | |
SG11202108304PA (en) | Enzymatic production of mannose | |
GB202210334D0 (en) | Methods of production of aginine-silicate complexes | |
PL3755681T3 (en) | Method of 4-boronophenylalanine production | |
SG10201914018UA (en) | Process of omega-hydroxyl fatty acid production | |
SG11202111111UA (en) | Production of salipro particles | |
GB201911958D0 (en) | Methods of t cell production | |
GB2584586B (en) | Method of production of particles | |
GB201811226D0 (en) | Method of manufacture using an additive manufacturing process | |
EP3977970C0 (en) | Production method for wearable article | |
IL272811A (en) | Production method of thiazole derivative | |
GB202117642D0 (en) | Methods of cardiomyocyte production | |
EP3289086A4 (en) | Method for production of heparin and heparan sulfate | |
PL3544068T3 (en) | Method of production of thermoelectric micro-coolers | |
HUP1800125A2 (en) | Process for production of iloprost | |
GB202019432D0 (en) | Bio-lpg production process | |
GB2587897B (en) | A method of production | |
GB202111169D0 (en) | Methods of T cell production | |
PH22021051420U1 (en) | Process of producing new cocoyam polvoron | |
HUE069037T2 (en) | Production method of a structure system | |
GB2585449B (en) | Improved pipe and method of production | |
GB202112937D0 (en) | Production of hepatocytes | |
HUE067878T2 (en) | Process for the manufacture of alkylamidothiazoles | |
GB201911909D0 (en) | Method of manufacturing microstructures | |
GB2578309B (en) | Method of stimulating hydrocarbon production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |